title: Gepirone hydrochloride: preclinical pharmacology and recent clinical findings.
authors.affiliation: Bristol-Myers Company, CNS Research, Pharmaceutical Research and Development Div., Wallingford, CT 06492.
authors.forename: J P
authors.initials: JP
authors.lastname: Yevich
authors.forename: M S
authors.initials: MS
authors.lastname: Eison
authors.forename: A S
authors.initials: AS
authors.lastname: Eison
authors.forename: D P
authors.initials: DP
authors.lastname: Taylor
authors.forename: F D
authors.initials: FD
authors.lastname: Yocca
authors.forename: C P
authors.initials: CP
authors.lastname: VanderMaelen
authors.forename: L A
authors.initials: LA
authors.lastname: Riblet
authors.forename: D S
authors.initials: DS
authors.lastname: Robinson
authors.forename: D L
authors.initials: DL
authors.lastname: Roberts
authors.forename: D L
authors.initials: DL
authors.lastname: Temple
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D006801:Humans; D011743:Pyrimidines / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D014151:Anti-Anxiety Agents; D011743:Pyrimidines; C039979:gepirone